| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.21 | 0.1 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |